Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_assertion wasGeneratedBy ECO_0000203 NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_assertion wasDerivedFrom befree-20150227 NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_assertion SIO_000772 23658459 NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_assertion evidence source_evidence_literature NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.
- NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_assertion description "[Dovitinib was then evaluated in a phase II trial that included 4 groups of patients with human EGF receptor 2-negative metastatic breast cancer on the basis of FGFR1 amplification and hormone receptor (HR) status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400533.RA1oWWAgfBIdhHmAKmq_fjLbTnuQMictmMFMPEEwZYvkw130_provenance.